BerGenBio Inks $8.8M Series A
BerGenBio, an oncology biopharma start-up, has raised $8.8 million in Series A financing from Norwegian venture investors Sarsia Seed AS and Investinor AS. The money will go toward taking its lead product into clinical trials. BerGenBio is based in Bergen, Norway.
9 January 2012•3 mins read
